Through the synergistic actions of the gut–liver axis, ICA further activates the PPARα/CD36 axis, effectively reducing hepatic lipid accumulation and, ultimately, improves liver function and growth performance in male IUGR piglets (Fig. 8). The gene discussed is PPARA; the disease is fetal growth restriction.